Skip to content

Company

Aclaris Therapeutics

United States

The ETFs we cover that hold this company, and its latest news.

Which ETFs hold Aclaris Therapeutics?

Held by 40 covered funds. Sorted by Aclaris Therapeutics’ share of each fund. Holdings as of each fund’s latest SEC filing.

FundShare of fund
XPHState Street(R) SPDR(R) S&P(R) Pharmaceuticals0.9%
QQQSInvesco NASDAQ Future Gen 2000.6%
SBIOALPS Medical Breakthroughs0.3%
IWCiShares Micro-Cap0.1%
FSEGFidelity Enhanced Small Cap Growth0.1%
FSEVFidelity Enhanced Small Cap Value0.1%
VFMOVanguard U.S. Momentum Factor0.1%
IBBiShares Biotechnology0.0%
IBBQInvesco Nasdaq Biotechnology0.0%
QOWZInvesco Nasdaq Free Cash Flow Achievers0.0%
IWOiShares Russell 2000 Growth0.0%
RESMColumbia Research Enhanced Small Cap0.0%
GSSCGoldman Sachs ActiveBeta(R) U.S. Small Cap Equity0.0%
VTWVVanguard Russell 2000 Value Index Fund0.0%
PRFZInvesco Rafi US 1500 Small-Mid0.0%
FESMFidelity Enhanced Small Cap Core0.0%
AVSCXAvantis U.S. Small Cap Equity Fund0.0%
RSSLGlobal X Russell 20000.0%
IWMiShares Russell 20000.0%
NSIDXSmall Cap Index Fund0.0%
AVSCAvantis U.S. Small Cap Equity0.0%
VTWOVanguard Russell 2000 Index Fund0.0%
ITWOProShares Russell 2000 High Income0.0%
RBProShares Russell 2000 Dynamic Buffer0.0%
VXFVanguard Extended Market Index Fund0.0%
SSMHXState Street Small/mid Cap Equity Index Portfolio0.0%
IWNiShares Russell 2000 Value0.0%
DFASDimensional U.S. Small Cap0.0%
DFSCXU.S. Micro Cap Portfolio0.0%
ITOTiShares Core S&P Total U.S. Stock Market0.0%
DFAUDimensional US Core Equity Market0.0%
IWViShares Russell 30000.0%
KCXSXKnights of Columbus U.S. ALL CAP INDEX FUND0.0%
VTIVanguard Total Stock Market Index Fund0.0%
VITPXVanguard Institutional Total Stock Market Index Fund0.0%
SSBIXState Street Balanced Index Fund0.0%
VTHRVanguard Russell 3000 Index Fund0.0%
DXUVDimensional US Vector Equity0.0%
DFACDimensional U.S. Core Equity 20.0%
DFQTXU.S. Core Equity 2 Portfolio0.0%

Where to buy these ETFs

[Affiliate and risk wording from the law firm]

Latest Aclaris Therapeutics news

No recent stories about Aclaris Therapeutics.